Literature DB >> 549184

Surface antigens as virulence factors in infection with Bacteroides fragilis.

D L Kasper, A B Onderdonk, B F Polk, J G Bartlett.   

Abstract

Organisms of the genus Bacteroides represent the major group of obligate anaerobes involved in human infections. Bacteroides usually cause either bacteremia or localized abscesses. Of the numerous species of Bacteroides, Bacteroides fragilis is the single most frequent clinical isolate. B. fragilis and Bacteroides melaninogenicus have chemically incomplete lipopolysaccharides as compared with the lipopolysaccharides (endotoxins) of aerobic bacteria, and the lipopolysaccharides of Bacteroides lack the biologic potency characteristic of endotoxin. This inactivity may account for the very infrequent occurrence of disseminated intravascular coagulation or purpura that can accompany sepsis due to these organisms. Furthermore, strains of B. fragilis have an immunologically common capsular polysaccharide. In an animal model of intraabdominal sepsis, the encapsulated strains caused abscesses when given without other organisms, but abscess formation from unencapsulated strains of Bacteroides generally required the administration of a synergistic aerobe. The abscesses caused by encapsulated strains were shown to be directly attributable to the capsular polysaccharide, which is an important virulence factor of this organism. Patients or experimental animals infected with B. fragilis develop antibodies to the capsular polysaccharide, and these antibodies can be detected in a radioactive antigen-binding assay.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 549184     DOI: 10.1093/clinids/1.2.278

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

1.  Isolation and characterization of outer membranes of Bacteroides thetaiotaomicron grown on different carbohydrates.

Authors:  S F Kotarski; A A Salyers
Journal:  J Bacteriol       Date:  1984-04       Impact factor: 3.490

2.  Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.

Authors:  C G Gemmell; P K Peterson; D Schmeling; J Mathews; P G Quie
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

3.  Effect of oxygen on Bacteroides fragilis survival after far-ultraviolet irradiation.

Authors:  D T Jones; F T Robb; D R Woods
Journal:  J Bacteriol       Date:  1980-12       Impact factor: 3.490

4.  The cell-surface antigens of Bacteroides thetaiotaomicron.

Authors:  F Meisel-Mikolajczyk; A Rokosz; W Kaca
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

5.  Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.

Authors:  T M Ellis; J T Barrett
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Radioimmunoassay for Bacteroides fragilis infections.

Authors:  W L Hoppes; J P Rissing; J W Smith; A C White
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

7.  Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.

Authors:  I Brook; J C Coolbaugh; R I Walker; E Weiss
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Piliated Bacteroides fragilis strains adhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains.

Authors:  C Pruzzo; B Dainelli; M Ricchetti
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

9.  Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.

Authors:  D L Kasper; A Weintraub; A A Lindberg; J Lönngren
Journal:  J Bacteriol       Date:  1983-02       Impact factor: 3.490

10.  Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.

Authors:  J C Hagen; W S Wood; T Hashimoto
Journal:  Eur J Clin Microbiol       Date:  1983-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.